| BMI | Body mass index |
| CEBP | CCAAT Enhancer binding protein beta gene |
| FDR | False discovery rate |
| GLP-1 | Glucagon like peptide 1 |
| HbA1c | Glycated hemoglobin |
| HDL | High-density lipoprotein |
| HOMA-IR | Homeostasis model assessment of insulin resistance |
| hsCRP | High-sensitivity C-reactive protein |
| IL-1β | Interleukin 1β |
| IL-6 | Interleukin 6 |
| IL-10 | Interleukin 10 |
| IPA | Ingenuity Pathway Analysis |
| KRAS | KRAS proto-oncogene, GTPase |
| LDL | Low-density lipoprotein |
| MetS | Metabolic Syndrome |
| miRNAs | microRNAs |
| NF-kB | Nuclear factor Kappa B |
| PBMC | Peripheral blood mononuclear cells |
| RIN | RNA integrity number |
| RT-qPCR | Reverse transcription quantitative PCR |
| SOCS1 | Suppressor of cytokine signaling 1 |
| TNF-α | Tumor necrosis factor alpha |
| T2D | Type 2 diabetes |
| VLDL | Very low-density lipoprotein |